SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-128542
Filing Date
2023-12-22
Accepted
2023-12-22 08:22:45
Documents
17
Period of Report
2023-12-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2333579d1_8k.htm   iXBRL 8-K 40709
2 EXHIBIT 3.1 tm2333579d1_ex3-1.htm EX-3.1 47469
3 EXHIBIT 4.1 tm2333579d1_ex4-1.htm EX-4.1 3923
4 EXHIBIT 10.1 tm2333579d1_ex10-1.htm EX-10.1 185476
8 GRAPHIC tm2333579d1_ex4-1img001.jpg GRAPHIC 204371
9 GRAPHIC tm2333579d1_ex4-1img002.jpg GRAPHIC 103802
  Complete submission text file 0001104659-23-128542.txt   940517

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA kala-20231221.xsd EX-101.SCH 3009
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE kala-20231221_lab.xml EX-101.LAB 34240
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kala-20231221_pre.xml EX-101.PRE 22355
11 EXTRACTED XBRL INSTANCE DOCUMENT tm2333579d1_8k_htm.xml XML 3315
Mailing Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476
Business Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 781-996-5252
KALA BIO, Inc. (Filer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38150 | Film No.: 231507208
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)